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Abstract
Objective—To investigate associations between work-related asthma-like symptoms (WASTH) 
and annual pulmonary function decline among employees of 18 Norwegian smelters.
Methods—A 5-year longitudinal study in which WASTH was defined as a combination of 
dyspnea and wheezing that improved on rest days and vacation.
Results—A total of 12,966 spirometry examinations were performed in 3084 employees. Crude 
annual decline in forced expiratory volume in 1 second (FEV1) (dFEV1) was 32.9 mL/yr (95% 
confidence interval, 30.5 to 35.3), and crude annual decline in forced vital capacity (FVC) (dFVC) 
was 40.9 mL/yr (37.8 to 43.9). After adjustment for relevant covariates, employees reporting 
WASTH showed higher dFEV1 by 16.0 m:/yr (3.4 to 28.6) and higher dFVC by 20.5 mL/yr (6.0 
to 35.0) compared with employees not reporting WASTH.
Conclusion—Work-related asthma-like symptom was associated with greater annual declines in 
FEV1 and FVC, indicating a restrictive pattern.
The Norwegian smelting industry produces ferrosilicon alloys (FeSi), silicon metal (Si-
metal), ferromanganese (FeMn), silicon manganese (SiMn), ferrochrome (FeCr), silicon 
carbide (SiC), and titanium(II) oxide (TiO2). These manufacturing processes emit several air 
pollutants into the workplace environment, including particulates and gases that are 
potentially harmful to airways.1,2 Factory workers are exposed to particles of the raw 
materials that are characteristic of each production type (ie, substances containing silicon, 
iron, manganese, chrome, and titanium) as well as minerals composed of these elements, 
such as quartz. Other exposures include particles and gases originating from combustion in 
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the furnaces, mainly carbon-containing dust that is contaminated by impurities of the anode, 
such as sulfur and other trace elements. Furthermore, several vehicles in the production halls 
produce air pollution, including diesel exhaust.
Apart from chrome,3 which constitutes only a minor part of the production, none of the 
predominantly involved elements are known sensitizers. Thus, the air pollution in a smelting 
workplace is dominated by nonspecific airway irritants. A subgroup of occupational asthma 
is caused by irritants,4,5 and such asthma may therefore occur in these work settings. 
Furthermore, subjects with occupational asthma reportedly exhibit an accelerated decline in 
forced expiratory volume in 1 second (FEV1),6 and it has been suggested that occupational 
asthma may cause chronic obstructive pulmonary disease.7
We previously found that dust exposure in smelters is associated with an accelerated annual 
decline in lung function8,9 and with increased prevalence of airflow limitation,10 indicating 
an elevated risk of chronic obstructive pulmonary disease.11 Moreover, our prior findings 
indicate that increasing dust exposure is positively associated with the incidence of work-
related asthma-like symptoms (WASTH) in the absence of doctor-diagnosed asthma.12 
These results suggest the possibility that WASTH represent a risk indicator of rapid decline 
in pulmonary function. Nevertheless, the association between WASTH and annual decline in 
pulmonary function has not been examined.
This study aimed to investigate whether WASTH was associated with accelerated annual 
decline in lung function.
METHODS
Study Population
All 20- to 55-year-old employees of 18 Norwegian smelters and related workplaces 
producing FeSi, Si-metal, FeMn, SiMn, FeCr, or SiC were invited to participate in this 
longitudinal respiratory study. A total of 3084 employees agreed to participate, representing 
approximately 90% of the workforce. The study started between 1996 and 1998 at different 
plants, and continued until 2003. New employees (n = 777) were included if they started to 
work in the industry during the study period. The employees were followed up annually, 
with a total of 12,996 observations. Examinations included spirometry measurements and a 
respiratory questionnaire, with a potential maximum of six data points for any one 
participant.13 Spirometry was performed as recommended by the European Community for 
Coal and Steel,14 and details have been previously published.15 The respiratory 
questionnaire asked the subjects to report their symptoms during the last year. Table 1 shows 
the characteristics of the study participants. The study was approved by the Regional Ethics 
Committee, South East Norway (208–04085).
Definitions
Doctor-diagnosed asthma was defined as asthma diagnosed by a physician during childhood 
or adulthood before the participant started their current job. Work-related asthma-like 
symptom was defined as dyspnea with wheeze that improved on days off of work and during 
holidays in a participant without doctor-diagnosed asthma. An employee was considered to 
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have an allergy if they had a history of either hay fever or atopic eczema. Familial asthma 
was defined as current or previous asthma in parents, grandparents, sisters, or brothers. 
Employees were defined as previously exposed if they answered “yes” to the question 
“Have you previously been exposed on a regular basis to fumes, dust, or irritating vapors 
(gases) during your work?”
Occupational Exposures
The questionnaire was used to collect information about job category and smoking habits 
during the previous year. Current occupational exposure was assessed using a quantitative 
job exposure matrix that was constructed as the geometric mean of total dust exposure in 
each job category in each smelter, and is explained in detail elsewhere.1,2 Briefly, dust from 
the working atmosphere was collected using personal samplers during the study period. The 
geometric mean of the dust exposure for the corresponding job title of the previous year was 
allocated to each employee. If an employee changed job categories during the year, a time-
weighted average of the relevant geometric means was used. At each yearly examination, we 
updated information on job category, thereby enabling qualitative as well as quantitative 
determination of dust exposure.
Statistical Analyses
The analyses were performed using the software PROC GLIMMIX (for generalized linear 
mixed model) and PROC MIXED (for linear mixed model) SAS version 9.4 (SAS Institute 
Inc, Cary, NC). First, we used a generalized linear mixed model with logit link to investigate 
the univariate associations between the prevalence of WASTH and categories of relevant 
covariates during follow-up. Next, we used linear mixed models to investigate the univariate 
associations between FEV1 as well as forced vital capacity (FVC) and follow-up time within 
categories of relevant covariates,16 with follow-up time measured as years elapsed after 
inclusion. Age was expressed as age at baseline.15 The coefficients of the univariate linear 
mixed model analyses were estimates of annual decline of FEV1 (dFEV1) and FVC (dFVC) 
with regard to the corresponding covariates.
Model fit was assessed using the Akaike information criterion, which revealed the lowest 
Akaike information criterion values (indicating a better fit) for models with an 
autoregressive moving average (ARMA 1,1) covariance matrix.15 Multivariate models for 
FEV1 and FVC were developed as follows. The initial model included all the covariates that 
were associated with WASTH prevalence and with dFEV1 or dFVC, with a corresponding P 
value of <0.2. The initial model also included interaction terms between the covariates and 
follow-up time. Then backward reduction of the models was performed—starting with the 
removal of nonsignificant product terms with follow-up time that did not change the product 
term between WASTH and follow-up time by more than 20%. Thereafter, nonsignificant 
main effects were removed if their corresponding product terms with follow-up time were 
removed from the model. Thus, the final model contained significant main effects and 
significant product terms between the covariates with their corresponding main effects and 
follow-up time.
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At baseline, 139 participants (4.5%) reported WASTH. Another 91 participants (3.0%) 
developed WASTH during follow-up (Table 1). There were a total of 449 reports of 
WASTH during the 12,996 follow-up examinations (3.5%). Compared with employees who 
never reported WASTH, those who reported WASTH showed a higher prevalence of 
smoking and a lower FEV1 at baseline. Figure 1 shows the mean FEV1, FVC, and 
FEV1/FVC ratio according to WASTH status at each follow-up. Among the employees who 
reported WASTH, all three variables were lower and the annual declines in FVC and FEV1 
were steeper. The FEV1/FVC ratio did not decline among employees reporting WASTH 
(0.05%/yr; 95% confidence interval [CI], −0.25% to 0.36%) or those who did not report 
WASTH (−0.03%/yr; 95% CI, −0.07% to 0.02%). The difference in annual change in the 
FEV1/FVC ratio between employees reporting WASTH and those who did not report 
WASTH was 0.09% (95% CI, −0.32% to 0.14%). The coefficient between FEV1/FVC ratio 
and age at baseline (among males) was −0.18% (95% CI, −0.21% to −0.15%).
Univariate analyses revealed that WASTH was positively associated (P < 0.2) with most 
covariates—including age at baseline, male sex, smoking habits, a history of familial 
asthma, previous exposure to dust or fumes, the type of production, and the level of current 
dust exposure—but was inversely associated with baseline FEV1 and FVC (Table 2). 
Annual decline in FEV1 was positively associated with each of these covariates, with the 
exception of a family history of asthma with which it showed an inverse relationship. 
Univariate estimates for dFVC revealed positive associations with all of the covariates, 
except the family history of asthma and baseline FEV1.
To investigate annual decline in spirometry according to WASTH status, we fit linear mixed 
models for FEV1 and FVC with the covariate follow-up time, WASTH, and the product of 
follow-up time and WASTH. This revealed steeper changes in dFEV1 (15.0 mL/yr; P = 
0.02) and dFVC (27.2 mL/yr; P = 0.0009) among employees reporting WASTH compared 
with those who did not report WASTH.
Table 3 summarizes the full results of multivariate linear mixed analyses for FVC and 
FEV1. Controlling for potential confounders, we found that participants who reported 
WASTH showed steeper dFEV1 by 16.0 mL/yr (95% CI, 2.1 to 27.1) and steeper dFVC by 
20.5 mL/yr (95% CI, 6.0 to 35.0). Both dFEV1 and dFVC increased with increasing age, 
with FVC at baseline, and with increasing dust exposure. In addition, dFEV1 was positively 
associated with increasing smoking status (from never to former to current) and with FVC at 
baseline.
DISCUSSION
Our present findings revealed that WASTH was significantly associated with increased 
dFEV1 and dFVC. It is important to identify subjects with increased risk of occupational 
health disorders to prevent future disability. The detection of subjects with increased annual 
decline in pulmonary function requires repeated spirometry examinations over several years. 
This is a costly practice, and interpretation of the results can be difficult although it can be 
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facilitated by available software.17 On the other hand, regular surveillance or at-risk 
employees via a self-administered questionnaire is much cheaper and should be considered 
as an alternative. Our present results confirmed that a combination of dyspnea and wheezing 
that improves on rest days and vacations seems to identify subjects with increased annual 
decline in pulmonary function. We found similar results in our previous small longitudinal 
study in the aluminum industry using the same questionnaire as in this study.18 
Nevertheless, such a method should not be routinely implemented without a validation study 
including estimations of the sensitivity, specificity, and costs—which was beyond the scope 
of this study.
Our present results also showed that smoking was associated with dFEV1 but not dFVC, and 
dust exposure was associated with increased annual decline in FEV1 as well as FVC. 
Nevertheless, subjects reporting WASTH did not show faster annual decline in the 
FEV1/FVC ratio than individuals who did not report WASTH. Hence, dust exposure could 
possibly have a restrictive effect on pulmonary function in these settings, which is most 
pronounced among subjects reporting WASTH.
Our previous investigations of annual decline in lung function and dust exposure from this 
cohort showed only a borderline significant association between annual decline in FVC and 
dust exposure.8,9 These prior publications expressed spirometric volumes per squared 
height, and treated dust exposure as a continuous covariate. The available data suggest that a 
restrictive component of the association between pulmonary function and dust exposure 
should be considered. It has also been previously reported that susceptible workers exposed 
to silica can develop obstructive, restrictive, or mixed patterns of reduced lung function.19 
Moreover, the presently found association between the FEV1/FVC ratio and age among 
males was very close to the European reference values (0.18% in both).14 This suggests that 
the total workforce had an annual decline of the FEV1/FVC ratio within the normal range, 
whereas WASTH was associated with a decline showing a restrictive pattern. This could be 
a false result, as it is easier to get reproducible measures of FEV1 than FVC. Nevertheless, it 
is unlikely that FVC measurements could be systematically reduced during follow-up; 
therefore, we believe that there was a steeper decline in FVC than FEV1.
The underlying pathophysiologic mechanism that corresponds to WASTH is unclear. In this 
study, current smoking was associated with accelerated decline in FEV1 but not in FVC, 
indicating different underlying mechanisms in subjects reporting WASTH compared with 
the effects of smoking. Moreover, the association between pulmonary function and other 
covariates, foremost smoking, differed in subjects reporting familial asthma compared with 
individuals who did not report familial asthma. This difference could be caused by 
clustering. Hence, it is possible that the effect modification of the association between 
decline in pulmonary function and WASTH could be spurious.
Compared with individuals having pulmonary function in the lowest range, subjects with 
high baseline FVC and FEV1 showed faster annual decline in both FVC and FEV1. Similar 
results have been reported in general populations.20,21 This suggests that a low level of 
pulmonary function to some extent counteracts the effect of other covariates that are 
determinants of accelerated decline, such as age. Our present data include some evidence of 
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slower annual decline of lung function with increasing age among subjects reporting 
WASTH. Although the corresponding P value was nonsignificant, a selection effect of 
subjects with WASTH cannot be excluded.
In this study, we ignored exposure levels on the basis of our previous findings that dust 
exposure was associated with the outcome (dFEV1) as well as the determinant (WASTH). 
Regarding the identification of subjects reporting WASTH for preventive purposes, the 
exposure level is of minor importance. Hence, annual surveillance of the workforce using a 
questionnaire could probably identify individuals with increased risk of decline in lung 
function and thereby prevent unnecessary spirometry of healthy individuals. Moreover, the 
health costs could be reduced. Nevertheless, the sensitivity and specificity of such strategy 
should be investigated. This was not done in this study. We believe that such subjects should 
be clinically examined with repeated spirometry examinations regardless of their exposure 
levels.
The main limitation of this study was the lack of clinical interpretation of the concept of 
WASTH. The symptoms are compatible with work-related asthma. Nevertheless, as 
occupational asthma has not been reported from these industries, it is unlikely that it is a 
major problem in this context. Rather, the spirometry results indicated a restrictive pattern 
among employees reporting WASTH. The clinical interpretation of these results is difficult, 
but it seems that WASTH identifies individuals at increased risk of loss of lung function. 
Thus, these findings should be of interest from a preventive point of view.
CONCLUSION
Work-related asthma-like symptom was associated with an increased annual decline in 
FEV1 as well as FVC, indicating a restrictive pattern. Identification of subjects reporting 
WASTH could be a useful tool for occupational health monitoring among smelters.
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The mean FVC, FEV1, and FEV1/FVC ratio with regression lines (dashed lines) during the 
follow-up. FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity.
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TABLE 1
Descriptive Data at Baseline of Employees Who Did/Did Not Report Work-Related Asthma-Like Symptoms 
During the Follow-Up
WASTH
Characteristic At Baseline Incident Cases Never WASTH
n (%) 139 (4.5) 91 (3.0) 2854 (92.5)
Age, yrs, mean (SD) 40.5 (8.4) 41.2 (9.0) 38.9 (9.2)
Male, n (%) 130 (93.5) 85 (93.4) 2,531 (88.9)
Smoking habits, n (%)
  Never 21 (15) 16 (18) 925 (32)
  Former 22 (16) 19 (21) 566 (20)
  Current 96 (69) 56 (62) 1363 (48)
Spirometry, mean (SD)
  FEV1, L 3.65 (0.82) 3.75 (0.74) 3.89 (0.73)
  FEV1, % predicted 83 (15) 86 (12) 89 (12)
  FVC, L 4.80 (0.97) 4.98 (0.98) 5.01 (0.92)
  FVC, % predicted 90 (14) 94 (13) 95 (12)
FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; SD, standard deviation; WASTH, work-related asthma-like symptoms.
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TABLE 2
Cumulative Number and Mean Prevalence (in Parentheses) of Work-Related Asthma-Like Symptoms During 
the Follow-Up, and Annual Decline in FEV1 and FVC in mL/yr by Selected Covariates
Characteristics WASTH n (%) dFEV1 Coefficient (95% CI) dFVC Coefficient (95% CI)
Age at baseline, yrs
  <35 89 (2.6) 22.9 (18.5 to 27.4) 25.9 (20.5 to 31.3)
  35–44 201 (3.7) 33.9 (30.0 to 37.8) 40.8 (35.9 to 45.6)
  ≥45 159 (3.9) 40.4 (36.3 to 44.5) 52.0 (46.9 to 57.1)
  P value for trend 0.014 <0.0001 <0.0001
Sex
  Female 25 (1.8) 18.9 (36.3 to 44.5) 30.0 (24.0 to 36.0)
  Male 424 (3.7) 34.1 (31.6 to 36.6) 41.3 (38.1 to 44.6)
  P value between groups 0.0007 <0.0001 0.023
Smoking habits
  Never 65 (1.7) 25.7 (21.0 to 30.4) 33.3 (27.7 to 38.9)
  Former 88 (3.0) 31.0 (25.8 to 36.2) 44.5 (38.1 to 50.8)
  Current 296 (4.8) 37.3 (34.0 to 40.6) 40.4 (36.1 to 44.8)
  P value for trend <0.0001 <0.0001 0.061
Familial asthma
  No 332 (3.3) 33.7 (31.1 to 36.3) 40.5 (37.1 to 43.9)
  Yes 117 (4.0) 28.0 (23.0 to 33.0) 38.6 (32.3 to 44.8)
  P value between groups 0.062 0.056 0.594
Previous exposure
  No 71 (1.9) 27.5 (23.0 to 32.1) 36.4 (30.7 to 42.0)
  Yes 378 (4.1) 34.1 (31.7 to 37.1) 41.6 (38.1 to 45.1)
  P value between groups <0.0001 0.009 0.118
Production
  SiC 46 (2.8) 15.9 (8.7 to 23.1) 37.0 (27.1 to 46.9)
  FeSi Si-metal 244 (3.4) 32.0 (28.8 to 35.3) 43.1 (39.0 to 47.3)
  FeMn/SiMn/FeCr 159 (3.8) 40.1 (36.1 to 44.0) 37.6 (32.9 to 42.4)
  P value for trend 0.070 <0.0001 0.582
Dust exposure, mg/m3
  <1.0 109 (2.3) 27.7 (23.9 to 31.4) 34.5 (29.9 to 39.1)
  1.9–2.9 200 (3.8) 31.8 (28.4 to 35.2) 37.1 (32.6 to 41.6)
  ≥3.0 140 (4.6) 41.8 (36.2 to 47.3) 53.5 (46.3 to 60.7)
  P value for trend <0.0001 0.0002 <0.0001
FEV1 at baseline, mL
  <3500 205 (4.7) 25.5 (20.8 to 30.2) 36.3 (30.6 to 42.0)
  3500–4490 196 (3.1) 34.4 (31.3 to 37.5) 41.4 (37.5 to 45.3)
  >4490 48 (2.2) 37.0 (31.5 to 42.5) 42.8 (35.5 to 50.0)
  P value for trend <0.0001 0.0002 0.906
FVC at baseline, mL
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Characteristics WASTH n (%) dFEV1 Coefficient (95% CI) dFVC Coefficient (95% CI)
  <4500 43 (4.5) 14.9 (4.5 to 23.7) 16.0 (3.0 to 29.1)
  4500–5490 148 (4.5) 25.7 (21.0 to 30.3) 30.2 (24.4 to 36.0)
  >5490 258 (3.0) 36.4 (33.5 to 39.4) 45.1 (41.5 to 48.7)
  P value for trend <0.0001 <0.024 <0.0001
All 449 (3.5) 32.9 (30.5 to 35.2) 40.9 (37.8 to 43.9)
CI, confidence interval; dFEV1, decline in dFEV1; dFVC, decline in dFVC; FeCr, ferrochrome; FeMn, ferromanganese; FeSi, ferrosilicon alloys; 
FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; SD, standard deviation; SiC, silicon carbide; Si-metal, silicon metal; 
SiMn, silicon manganese; WASTH, work-related asthma-like symptoms.
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TABLE 3
Results of the Multivariate Analyses With 95% Confidence Intervals in Parentheses
Covariate FVC, mL FEV1, mL
Intercept −3724 (−4192 to −3256) −1370 (−1807 to −932)
Follow-up time, yrs 2.8 (−10.6 to 16.0) 15.4 (3.0 to 27.7)
Height, cm 45.3 (42.7 to 47.9) 25.9 (23.4 to 30.6)
Male vs female 286 (218 to 354) 84.4 (18.2 to 151)
Age at baseline, yrs
  35–44 −25.1 (−50.0 to −0.31) −34.7 (−56.5 to −12.8)
  ≥45 −358 (−401 to −314) −377 (−418 to −336)
  P value for trend <0.0001 <0.0001
Smoking habits
  Former vs never −30.0 (−64.3 to 4.3) −55.0 (−85.3 to −24.6)
  Current vs never −29.9 (−57.7 to −2.1) −49.7 (−74.4 to −25.0)
  P value for trend 0.997 0.112
FVC at baseline, mL
  4500–5490 468 (424 to 512) 356 (272 to 440)
  ≥5500 979 (932 to 1025) 1013 (926 to 1101)
  P value for trend <0.0001 <0.0001
Dust exposure, mg/m3
  1.0–2.9 −5.4 (−28.5 to 17.6) 0.48 (−19.8 to 20.7)
  ≥3.0 12.5 (−15.1 to 40.0) 11.3 (−13.0 to 35.5)
  P value for trend 0.123 0.911
  WASTH: yes vs no 6.6 (−27.5 to 40.7) 7.4 (−22.4 to 37.1)
Annual Decline dFVC, mL/yr dFEV1, mL/yr
Age at base line, years
  35–44 vs <35 12.6 (5.5 to 19.7) 11.0 (4.8 to 17.2)
  ≥45 vs <35 24.8 (16.9 to 32.7) 25.7 (18.9 to 32.6)
  P value for trend <0.0001 <0.0001
Smoking habits
  Former vs never 5.9 (−1.7 to 13.4) 1.7 (−4.8 to 8.3)
  Current vs never 4.8 (−1.6 to 11.1) 9.7 (4.2 to 15.2)
  P value for trend 0.416 <0.0001
FVC at baseline, mL
  4500–5490 vs <4500 4.8 (−7.1 to 16.8) 15.2 (3.7 to 26.7)
  ≥5500 vs <4500 14.3 (2.8 to 25.7) 28.3 (17.4 to 39.3)
  P value for trend <0.0001 <0.0001
Dust exposure, mg/m3
  1.0–2.9 vs <1.0 0.50 (−5.6 to 6.6) 2.2 (−3.1 to 7.5)
  ≥3.0 vs <1.0 13.3 (6.2 to 20.3) 11.9 (5.7 to 18.1)
  P value for trend <0.0001 0.0009
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Covariate FVC, mL FEV1, mL
  WASTH: yes vs no 20.5 (6.0 to 35.0) 16.0 (3.4 to 28.6)
dFEV1, decline in dFEV1; dFVC, decline in dFVC; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; WASTH, work-
related asthma-like symptoms.
J Occup Environ Med. Author manuscript; available in PMC 2015 November 30.
